M&As this week: Straumann Holding AG, Edwards Life Sciences

1 December 2016 (Last Updated December 1st, 2016 18:30)

Straumann Holding AG, a medical device company, has announced its decision to acquire an additional 49% stake to become a 100% stake holder in Medentika GmbH, a medical device company.

Straumann Holding AG, a medical device company, has announced its decision to acquire an additional 49% stake to become a 100% stake holder in Medentika GmbH, a medical device company.

Pursuant to the acquisition, the ownership and management groups of the two companies will remain the same and the founding shareholders will play an active role in the companies.

"The ownership and management groups of the two companies will remain the same and the founding shareholders will play an active role in the companies."

Edwards Life Sciences has announced it is to acquire Valtech Cardio, a cardioband system developer based in Israel, for a purchase consideration of $340m.

According to the agreement, Valtech Cardio will spin off its early-stage transseptal mitral valve replacement technology programme with Edwards Life Sciences and will, in return, receive additional mile stone payments of approximately $350m from the acquirer.